Dexmedetomidine protects against apoptosis induced by hypoxia/reoxygenation through the inhibition of gap junctions in NRK-52E cells

Life Sciences

Volumn 122, Issue , 2015, Pages 72-77

  Luo, Chenfang ^a   Yuan, Dongdong ^a   Yao, Weifeng ^a   Cai, Jun ^a   Zhou, Shaoli ^a   Zhang, Yihan ^a   Hei, Ziqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Apoptosis; Dexmedetomidine; Gap junction intercellular communication; HeLa cell; Hypoxia reoxygenation; NRK 52E cell

Indexed keywords

CONNEXIN 32; DEXMEDETOMIDINE; HEPTANOL; RETINOIC ACID; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; OXYGEN; PROTECTIVE AGENT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COMMUNICATION; CONTROLLED STUDY; GAP JUNCTION; GENETIC TRANSFECTION; HELA CELL LINE; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; KIDNEY PROXIMAL TUBULE; NONHUMAN; PLASMID; PROTEIN EXPRESSION; RAT; REOXYGENATION; WESTERN BLOTTING; ANIMAL; ANOXIA; CELL CULTURE; CELL PROLIFERATION; DRUG EFFECTS; FLOW CYTOMETRY; KIDNEY TUBULE; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

RATTUS;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; ANOXIA; APOPTOSIS; BLOTTING, WESTERN; CELL COMMUNICATION; CELL PROLIFERATION; CELLS, CULTURED; DEXMEDETOMIDINE; FLOW CYTOMETRY; GAP JUNCTIONS; HELA CELLS; HUMANS; KIDNEY TUBULES; MALE; OXYGEN; PROTECTIVE AGENTS; RATS; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 84920063127     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.12.009     Document Type: Article

References (40)

1. S. An, X. Zang, W. Yuan, Y. Zhuge, Q. Yu, Neutrophil gelatinase-associated lipocalin (NGAL) may play a protective role against rats ischemia/reperfusion renal injury via inhibiting tubular epithelial cell apoptosis, Ren. Fail. 35 (2013) 143-149.
2. F.T. Billings, S.W. Chen, M. Kim, S.W. Park, J.H. Song, S. Wang, et al., Alpha2-adrenergic agonists protect against radiocontrast-induced nephropathy in mice. American Journal of Physiology, Ren. Physiol. 295 (2008) F741-F748.
3. A.M. Caetano, P.T. Vianna Filho, Y.M. Castiglia, M.A. Golim, A.V. de Souza, L.R. de Carvalho, et al., Erythropoietin attenuates apoptosis after ischemia-reperfusion-induced renal injury in transiently hyperglycemic Wister rats, Transplant. Proc. 43 (2011) 3618-3621.
4. J.E. Contreras, H.A. Sanchez, L.P. Veliz, F.F. Bukauskas, M.V. Bennett, J.C. Saez, Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue, Brain Res. Brain Res. Rev. 47 (2004) 290-303.
5. M.A. Daemen, C. van't Veer, G. Denecker, V.H. Heemskerk, T.G. Wolfs, M. Clauss, et al., Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation, J. Clin. Invest. 104 (1999) 541-549.
6. E. Decrock, M. Vinken, E. De Vuyst, D.V. Krysko, K. D'Herde, T. Vanhaecke, et al., Connexin-related signaling in cell death: to live or let die? Cell Death Differ. 16 (2009) 524-536.
7. K. Engelhard, C. Werner, E. Eberspacher, M. Bachl, M. Blobner, E. Hildt, et al., The effect of the alpha 2-agonist dexmedetomidine and the N-methyl- D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats, Anesth. Analg. 96 (2003) 524-531 (table of contents).
8. K. Engelhard, C. Werner, E. Eberspacher, M. Pape, M. Blobner, P. Hutzler, et al., Sevoflurane and propofol influence the expression of apoptosis-regulating proteins after cerebral ischaemia and reperfusion in rats, Eur. J. Anaesthesiol. 21 (2004) 530-537.
9. E. Farag, M. Argalious, A. Abd-Elsayed, Z. Ebrahim, D.J. Doyle, The use of dexmedetomidine in anesthesia and intensive care: a review, Curr. Pharm. Des. 18 (2012) 6257-6265.
10. E. Fujimoto, T. Yano, H. Sato, K. Hagiwara, H. Yamasaki, S. Shirai, et al., Cytotoxic effect of the Her-2/Her-1 inhibitor PKI-166 on renal cancer cells expressing the connexin 32 gene, J. Pharmacol. Sci. 97 (2005) 294-298.
11. G.S. Goldberg, J.F. Bechberger, C.C. Naus, A pre-loadingmethod of evaluating gap junctional communication by fluorescent dye transfer, Biotechniques 18 (1995) 490-497.
12. J. Gu, P. Sun, H. Zhao, H.R. Watts, R.D. Sanders, N. Terrando, et al., Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice, Crit. Care 15 (2011) R153.
13. D.S. He, J.M. Burt, Mechanism and selectivity of the effects of halothane on gap junction channel function, Circ. Res. 86 (2000) E104-E109.
14. F. Huang, S. Li, X. Gan, R. Wang, Z. Chen, Propofol inhibits gap junctions by attenuating sevoflurane-induced cytotoxicity against rat liver cells in vitro, Eur. J. Anaesthesiol. (2013).
15. N. Kanaya, H. Kimura, M. Nakayama, H. Tsuchida, H. Ohshika, A. Namiki, The direct effect of halothane on myocardial contraction in rat myocytes with poorly developed gap junctional intercellular communication, Acta Anaesthesiol. Scand. 43 (1999) 91-96.
16. H. Kishikawa, K. Kobayashi, K. Takemori, T. Okabe, K. Ito, A. Sakamoto, The effects of dexmedetomidine on human neutrophil apoptosis, Biomed. Res. 29 (2008) 189-194.
17. I.V. Koreen, W.A. Elsayed, Y.J. Liu, A.L. Harris, Tetracycline-regulated expression enables purification and functional analysis of recombinant connexin channels from mammalian cells, Biochem. J. 383 (2004) 111-119.
18. D.V. Krysko, L. Leybaert, P. Vandenabeele, K. D 'Herde, Gap junctions and the propagation of cell survival and cell death signals, Apoptosis 10 (2005) 459-469.
19. H.P. Leichtweiss, D.W. Lubbers, C. Weiss, H. Baumgartl, W. Reschke, The oxygen supply of the rat kidney: measurements of int4arenal pO2, Pflugers Arch. - Eur. J. Physiol. 309 (1969) 328-349.
20. D. Lin, D.J. Takemoto, Oxidative activation of protein kinase Cgamma through the C1 domain. Effects on gap junctions, J. Biol. Chem. 280 (2005) 13682-13693.
21. J.H. Lin, J. Yang, S. Liu, T. Takano, X. Wang, Q. Gao, et al., Connexin mediates gap junction-independent resistance to cellular injury, J. Neurosci. 23 (2003) 430-441.
22. B. Liu, Q. Wang, D.D. Yuan, X.T. Hong, L. Tao, Berberine potentizes apoptosis induced by X-rays irradiation probably through modulation of gap junctions, Chin. Med. J. 124 (2011) 1221-1228.
23. E. Masaki, M. Kawamura, F. Kato, Attenuation of gap-junction-mediated signaling facilitated anesthetic effect of sevo flurane in the central nervous system of rats, Anesth. Analg. 98 (2004) 647-652 (table of contents).
24. A. Naiki-Ito, M. Asamoto, T. Naiki, K. Ogawa, S. Takahashi, S. Sato, et al., Gap junction dysfunction reduces acetaminophen hepatotoxicity with impact on apoptotic signaling and connexin 43 protein induction in rat, Toxicol. Pathol. 38 (2010) 280-286.
25. J. Neijssen, B. Pang, J. Neefjes, Gap junction-mediated intercellular communication in the immune system, Prog. Biophys. Mol. Biol. 94 (2007) 207-218.
26. B.J. Padanilam, Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis, Am. J. Physiol. Ren. Physiol. 284 (2003) F608-F627.
27. V. Paschon, G.S.V. Higa, R.R. Resende, L.R.G.L. Britto, A.H.A. Kihara, Blocking of connexin-mediated communication promotes neuroprotection during acute degeneration induced by mechanical trauma, PLoS One 7 (2012).
28. P.M. Peixoto, S.Y. Ryu, D.P. Pruzansky, M. Kuriakose, A. Gilmore, K.W. Kinnally, Mitochondrial apoptosis is amplified through gap junctions, Biochem. Biophys. Res. Commun. 390 (2009) 38-43.
29. I. Plante, M. Charbonneau, D.G. Cyr, Activation of the integrin-linked kinase pathway downregulates hepatic connexin32 via nuclear Akt, Carcinogenesis 27 (2006) 1923-1929.
30. K. Sainio, S.F. Gilbert, E. Lehtonen, M. Nishi, N.M. Kumar, N.B. Gilula, et al., Differential expression of gap junction mRNAs and proteins in the developing murine kidney and in experimentally induced nephric mesenchymes, Development 115 (1992) 827-837.
31. R.D. Sanders, J. Xu, Y. Shu, A. Januszewski, S. Halder, A. Fidalgo, et al., Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats, Anesthesiology 110 (2009) 1077-1085.
32. C. Sauvant, R. Schneider, H. Holzinger, S. Renker, C. Wanner, M. Gekle, Implementation of an in vitro model system for investigation of reperfusion damage after renal ischemia, Cell. Physiol. Biochem. 24 (2009) 567-576.
33. Y. Si, H. Bao, L. Han, H. Shi, Y. Zhang, L. Xu, et al., Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation, J. Transl. Med. 11 (2013) 141.
34. S. Sugita, T. Okabe, A. Sakamoto, Continuous infusion of dexmedetomidine improves renal ischemia- reperfusion injury in rat kidney, J. Nippon Med. Sch. 80 (2013) 131-139.
35. N. Udaka, T. Ito, Y. Sato, S. Satoh, M. Kanisawa, Expression of connexin 32 gap junction protein in the kidneys during fetal development of the hamster (Mesocricetus auratus), Anat. Embryol. 192 (1995) 399-406.
36. L.J. Voss, S. Melin, G. Jacobson, J.W. Sleigh, Role of Cx36 gap junction modulation in general anaesthetic anticonvulsant action, Eur. J. Pharmacol. 643 (2010) 58-62.
37. M. Wang, V.M. Berthoud, E.C. Beyer, Connexin43 increases the sensitivity of prostate cancer cells to TNFalpha-induced apoptosis, J. Cell Sci. 120 (2007) 320-329.
38. F. Zhang, T. Ding, L. Yu, Y. Zhong, H. Dai, M. Yan, Dexmedetomidine protects against oxygen-glucose deprivation-induced injury through the I2 imidazoline receptor-PI3K/AKT pathway in rat C6 glioma cells, J. Pharm. Pharmacol. 64 (2012) 120-127.
39. Z. Zhao, R. Guan, S. Song, M. Zhang, F. Liu, M. Guo, et al., Sinomenine protects mice against ischemia reperfusion induced renal injury by attenuating inflammatory response and tubular cell apoptosis, Int. J. Clin. Exp. Pathol. 6 (2013) 1702-1712.
40. S.P. Zhou, W.T. Liao, L.K. Yang, L. Sun, Effects of sevoflurane pretreatment on renal Src and FAK expression in diabetic rats after renal ischemia/reperfusion injury, Mol. Cell. Biochem. 384 (2013) 203-211.